Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT05972122 Recruiting - Lung Diseases Clinical Trials

Serratus Posterior Superior Interfascial Plane Block for Thoracoscopic Surgery

Start date: August 9, 2023
Phase: N/A
Study type: Interventional

Regional techniques can be used for postoperative pain control following VATS. Ultrasound (US) guided serratus posterior superior block (SPSPB) is a new interfacial plane block defined by Tulgar et al in 2023. It is based on injection on the serratus posterior superior muscle at the level of the 2nd or 3rd rib. This block provides analgesia in conditions such as interscapular pain, chronic myofascial pain syndromes, scapulocostal syndrome, and shoulder pain. The SPS muscle is located at the C7-T2 level. It attaches to the lateral edges of the second and fifth ribs. It is innervated by the lower cervical and upper intercostal nerves. With the SPS block, these nerves are blocked and analgesia is provided.

NCT ID: NCT05970848 Not yet recruiting - Pulmonary Disease Clinical Trials

Washing Pipe With a Spray Nozzle for Topical Anesthesia During Bronchoscopy

Start date: July 2023
Phase: N/A
Study type: Interventional

The goal of this randomized control trial is to evaluate the effectiveness and safety of using a spray nozzle, compared to the conventional method, for topical anesthesia by the spray-as-you-go technique in reducing cough frequency, improving cough, discomfort, tolerance, satisfaction, reducing the dosage of lidocaine consumption of patients during flexible bronchoscopy.

NCT ID: NCT05967117 Recruiting - Pulmonary Disease Clinical Trials

Chest CT Using Low-concentration Iodine Contrast Media

Start date: November 24, 2023
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the quality of images when low-concentration iodine contrast agents is used in chest CT with low tube voltage and if they can be used in routine imaging. The primary endpoint of the study was the quality of the image and comparison of chest CT by using low and conventional concentration iodine contrast agents with low tube voltage and chest CT by using the conventional concentration iodine contrast agents with the conventional tube voltage; The secondary endpoint is optimizing chest CT protocol using an iodine contrast agent.

NCT ID: NCT05967091 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Ryme Medical TLD Pilot Study

Start date: September 2023
Phase: N/A
Study type: Interventional

Targeted lung denervation (TLD) with the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD) - Ryme Medical TLD Pilot Study

NCT ID: NCT05964491 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Video Resources for People With Chronic Obstructive Pulmonary Disease: An Exploratory Qualitative Study

Start date: October 20, 2022
Phase:
Study type: Observational

The IPCRG & Teesside University have searched the internet for video self management content for people living with COPD. Resources were reviewed by healthcare professionals and developed into a digital magazine to support people living with chronic obstructive Pulmonary Disease (COPD). The aims of this study are to 1. evaluate the use of the digital magazine format with video self-management content from an end user perspective, including 1. what characteristics a good video resource should have 2. what information is important to people with COPD to include in videos and digital magazines, 3. the useability of a digital magazine format 2. Explore the opinions, experiences and preferences of people living with COPD for accessing online self-management content including barriers and facilitators for accessing online self-management video content

NCT ID: NCT05963048 Completed - Clinical trials for Interstitial Lung Disease

Rituxmab Versus IL-6 in Treating ILD

Start date: December 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

All SSc patients should know if they have been diagnosed with interstitial lung disease, or pulmonary hypertension and keep results from his/her last pulmonary function test, chest imaging, echocardiogram and stress test

NCT ID: NCT05957198 Completed - Clinical trials for Lung Diseases, Interstitial

Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

Start date: July 25, 2023
Phase:
Study type: Observational

The purpose of this study is to describe initiation and use of oxygen therapy among patients with fibrotic Interstitial Lung Disease (ILD) and to assess the impact of oxygen therapy on clinical outcomes among patients with fibrotic ILD.

NCT ID: NCT05948904 Recruiting - Lung Diseases Clinical Trials

Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.

CT0129
Start date: November 3, 2023
Phase: N/A
Study type: Interventional

Developing a standardized methodology for the use of novel cryogenic catheters for transbronchial cryobiopsy and cryoablation of pulmonary lesions.

NCT ID: NCT05948891 Recruiting - COPD Clinical Trials

Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study

TriNEXT
Start date: August 1, 2023
Phase:
Study type: Observational

This is an observational, prospective, multicentric, cohort study conducted in France to evaluate the QoL in COPD patients treated with TRIMBOW NEXThaler 88/5/9 in a routine clinical practice setting. Patients enrolled in this study will be patients diagnosed with a COPD with a ratio of post-bronchodilator (salbutamol 400 μg) forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) of less than 0.7 to whom TRIMBOW NEXThaler 88/5/9 has been initiated by an hospital or local pulmonologists in accordance with clinical practice and marketing authorization.

NCT ID: NCT05947422 Not yet recruiting - Clinical trials for Interstitial Lung Disease

CT Quantitative Assessment of Interstitial Lung Disease

Start date: August 1, 2023
Phase:
Study type: Observational [Patient Registry]

Interstitial lung disease (ILD) refers to a broad category of heterogeneous lung diseases with different etiologies and features characterized by inflammation and fibrosis of the lung parenchyma and manifested as exertional dyspnea, interstitial patterns on high resolution computed tomography (HRCT), and abnormal pulmonary function tests (PFTs) The aim of this study is to investigate is there any correlation between changes seen in the lung parenchyma by HRCT and the pulmonary functions of the patients.